Working… Menu

Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS (PREDICT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01995981
Recruitment Status : Completed
First Posted : November 27, 2013
Last Update Posted : December 19, 2017
Information provided by (Responsible Party):
Radboud University